Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874716-25-000121
Filing Date
2025-08-04
Accepted
2025-08-04 16:22:36
Documents
100
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idxx-20250630.htm   iXBRL 10-Q 2193489
2 EX-31.1 idxx2025q210-qexhibit311.htm EX-31.1 10728
3 EX-31.2 idxx2025q210-qexhibit312.htm EX-31.2 10741
4 EX-32.1 idxx2025q210-qexhibit321.htm EX-32.1 5806
5 EX-32.2 idxx2025q210-qexhibit322.htm EX-32.2 6005
11 GRAPHIC idxx-20250630_g1.gif GRAPHIC 6646
  Complete submission text file 0000874716-25-000121.txt   9896310

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20250630.xsd EX-101.SCH 57135
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idxx-20250630_cal.xml EX-101.CAL 88166
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20250630_def.xml EX-101.DEF 253750
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20250630_lab.xml EX-101.LAB 698041
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20250630_pre.xml EX-101.PRE 507217
103 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20250630_htm.xml XML 1659373
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19271 | Film No.: 251180603
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)